SUVRETTA CAPITAL MANAGEMENT, LLC 13D and 13G filings for Terns Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 3:41 pm Sale |
2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN |
SUVRETTA CAPITAL MANAGEMENT, LLC | 0 0.000% |
-5,837,126 (Position Closed) |
Filing |
| 2024-02-13 11:44 am Purchase |
2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,837,126 9.500% |
2,388,851 (+69.28%) |
Filing |
| 2023-01-03 4:58 pm Purchase |
2022-12-21 | 13G | Terns Pharmaceuticals, Inc. TERN |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,448,275 7.000% |
3,448,275 (New Position) |
Filing |